News
Astra Breast Cancer Pill Slows Disease by Over 6 Months
Digest more
Ochre Bio appoints ex- Eli Lilly and AstraZeneca VP as Non-Executive DirectorThe appointment and ongoing science team expansion will help the company advance late-stage liver disease therapeutics29th ...
Last week, readers were most interested in a story about what's up Roche's sleeve as it talked about its plans during its investor day.
Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if ...
Researchers at ASCO's annual meeting also discussed the importance of repeat biopsies to assess HER2 status after first-line treatment.
The companies will develop and commercialize diagnostic tools to help clinicians determine which patients would benefit from precision medicine treatments.
A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...
Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback